Sept. 6 (UPI) -- Moderna announced on Wednesday that its updated COVID-19 vaccine pending approval by the Food and Drug Administration is effective against the new, highly mutated variant of the virus.
The drugmaker said its vaccine update for the fall has generated an 8.7-fold increase in neutralizing antibodies in humans against BA.2.86, or Pirola, in clinical trials.